Article · Wikipedia archive · Last revised Jun 23, 2026

Propylisopropyltryptamine

Propylisopropyltryptamine (PiPT), also known as N-propyl-N-isopropyltryptamine, is a psychedelic drug of the tryptamine family. It reportedly produces hallucinogenic effects that resemble those of other related dialkyl tryptamine derivatives, although PiPT is reportedly relatively weak and short-lasting. It has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.

Last revised
Jun 23, 2026
Read time
≈ 2 min
Length
351 w
Citations
6
Source
Wikipedia ↗
PiPT
Clinical data
Other namesPiPT; N-Propyl-N-isopropyltryptamine
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • none
Identifiers
  • [2-(1H-indol-3-yl)ethyl]-N-propyl-N-isopropylamine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H24N2
Molar mass244.382 g·mol−1
3D model (JSmol)
  • CC(C)N(CCC)CCc2c[nH]c1ccccc12
  • InChI=1S/C16H24N2/c1-4-10-18(13(2)3)11-9-14-12-17-16-8-6-5-7-15(14)16/h5-8,12-13,17H,4,9-11H2,1-3H3 checkY
  • Key:OFXPLOPRCQJJFP-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Propylisopropyltryptamine (PiPT), also known as N-propyl-N-isopropyltryptamine, is a psychedelic drug of the tryptamine family. It reportedly produces hallucinogenic effects that resemble those of other related dialkyl tryptamine derivatives,1 although PiPT is reportedly relatively weak and short-lasting. It has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.2

Use and effects

According to Alexander Shulgin in his 1997 book TiHKAL (Tryptamines I Have Known and Loved), PiPT had not yet been evaluated.3

Interactions

Chemistry

PiPT is short for N-propyl-N-isopropyltryptamine. PiPT is a tryptamine, which all belong to a larger family of compounds known as indolethylamines

Analogues

Analogues of PiPT include methylisopropyltryptamine (MiPT), ethylisopropyltryptamine (EiPT), diisopropyltryptamine (DiPT), and dipropyltryptamine (DPT), among others.3

Society and culture

Canada

PiPT is not a controlled substance in Canada as of 2025.4

United States

PiPT is not an explicitly controlled substance in the United States.5 However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption.

See also

See also

References

References

  1. Catalani V, Corkery JM, Guirguis A, Napoletano F, Arillotta D, Zangani C, Vento A, Schifano F (August 2021). "Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise". European Neuropsychopharmacology. 49: 69–92. doi:10.1016/j.euroneuro.2021.03.006. hdl:2299/24309. PMID 33857740. S2CID 233206904.
  2. Knill A, Tobias S, Matthews J, Ti L (June 2022). A Report on British Columbia’s Unregulated Drug Supply. Drug checking trends across British Columbia, January to December 2021 (PDF). British Columbia Centre on Substance Use (Report).
  3. Shulgin, Alexander; Shulgin, Ann (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252.
  4. "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
  5. Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
External links